Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.

O, Hanon; JS, Vidal; S, Lehmann; S, Bombois; B, Allinquant; JM, Tréluyer; P, Gelé; C, Delmaire; F, Blanc; JF, Mangin; L, Buée; J, Touchon; J, Hugon; B, Vellas; E, Galbrun; A, Benetos; G, Berrut; E, Paillaud; D, Wallon; G, Castelnovo; L, Volpe-Gillot; M, Paccalin; PH, Robert; O, Godefroy; T, Dantoine; V, Camus; J, Belmin; P, Vandel; JL, Novella; E, Duron; AS, Rigaud; S, Schraen-Maschke; A, Gabelle

doi:10.1016/j.jalz.2018.01.004

Public

Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.

Shared by NobleBlocks on Feb 17, 2018 • 12:00 AM UTC

Authors:

Hanon O

Vidal JS

Lehmann S

Abstract

Introduction Diagnostic relevance of plasma amyloid β (Aβ) for Alzheimer's disease (AD) process yields conflicting results. The objective of the study was to assess plasma levels of Aβ42 and Aβ40 in amnestic mild cognitive impairment (MCI), nonamnestic MCI, and AD patients and to investigate relatio...

Subject

Alzheimer's disease

Dementia

Cohort study

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!